UK: Living Happily Ever After With Diabetes

Last Updated: 29 November 2016
Article by Mina Hinsch

November 14th was World Diabetes Day.i Today in the UK there are some 3.5 million people diagnosed with diabetes and 549,000 people living, unknowingly, with the condition. In 2015, diabetes cost the NHS some £10 billion, however, the real cost to the individual is the debilitating effect of the disease and the increased risk of developing life-threatening complications. People with diabetes are twice as likely to be admitted to hospital and, every day in the UK, some 65 people die prematurely from complications of diabetes. Improving the management of diabetes has significant implications for patient outcomes and reducing healthcare costs.ii This week's blog is a personal story of living with diabetes type 1 and the impact that health technology can have on improving diabetics' lives.

Earlier this summer I went shopping for a wedding dress with my best friend. What a special moment. Between lace, colour, and style, the most important selection criteria for my friend was:

"Will it accommodate my insulin pump and where will I place my continuous blood glucose sensor"?

Diabetes is a condition where the levels of glucose in the body become too high because the pancreas fails to produce any, or inadequate levels of, insulin. There are two types of the diabetes:

  • Type 1 diabetes, a life-long condition affecting about 10 per cent of diabetes patients. It occurs as a result of the destruction of insulin-producing cells and, following diagnosis, is treated by daily insulin doses, either by injections or via an insulin pump. It usually develops before the age of 40, and most commonly in childhood.
  • Type 2 diabetes, usually occurs in people over the age of 40. It is also becoming increasingly common in children and adolescents. It occurs when insulin-producing cells fail to produce enough insulin or the insulin produced is inadequate. It accounts for between 85 and 95 per cent of diabetics and is closely linked to life-style factors. If diagnosed early enough, it can be managed by losing weight, a healthy diet and increasing physical activity. Otherwise, treatment involves oral medication and eventually direct injection of insulin.iii

The inexorable increase in diabetes prevalence is largely due to the increase in type 2 diabetes. However, understanding what it means to live with life-long, type 1 diabetes can provide lessons and an incentive for better managing the 'slow epidemic' of preventable type 2 diabetes.

My friend was diagnosed with type 1 diabetes when we were teenagers in Germany. Our close friendship over the intervening years has given me the opportunity to see first-hand the impact diabetes can have but also share in the increased freedom that new technological developments have granted her. This includes travelling, a passion for rock-climbing and pursuing a career as a gynaecologist. Improvements in technology have also enabled my friend to reduce her risk of complications by optimising her average blood sugar levels.

From the outset, my friend's management of her diabetes involved the use of an insulin pump, allowing her to match the administration of long- and short-acting insulin to her lifestyle- rather than constraining her life to fixed daily insulin injections. Previously this would have required her to prick her fingers several times a day to self-monitor her blood sugar, while leaving gaps in monitoring that she called 'flying blind'. More recently, she has been able to avoid both by using a continuous blood glucose sensor which allows seamless monitoring and has resulted in improved management of her condition.

While she values the sensor highly, she had initially faced challenges obtaining funding for the device from her insurance company. She enjoys the flexibility of using an app on her phone for measuring and recording her blood sugar, however she does worry about data security and privacy. Meanwhile, her sights are set on upscaling to an 'artificial pancreas' system. This close-loop system consists of a sensor capable of continuously monitoring glucose levels and integrating with an insulin pump that autonomously calculates and administers the necessary treatment.iv

Unfortunately, many people living with diabetes today don't have access to these life-changing technologies. This is due to regulatory, cost and funding challenges, underpinned by a lack of understanding of the disease and limited awareness of technological developments, compounded by a reluctance among patients and staff to adopt new technology.

For others to enjoy the benefits that my friend now enjoys and at the same time alleviate some of the demand pressures on healthcare services, our UK health system needs to take the following steps.

Improving awareness of diabetes and its risks

Globally, as many as one in two of all patients with diabetes are undiagnosed (an estimated 193 million). Awareness campaigns and use of online questionnaires can help overcome the lack of knowledge about causes and risks of the disease.v On-line education and patient activation programmes can improve prevention, increase early diagnosis and reduce complications.vi

Enhancing early diagnosis and monitoring

New non-invasive screening to predict diabetes risks can speed up access to care. They also improve long-term management, enable tailored treatment and reduce the risk of life-threatening complications. One such tool uses visible light to assess skin biomarkers, whilst another uses tear drop or salivary assessments.vii These new technologies have yet to be widely adopted, rather, the focus has been on low cost, easy use diagnostic tools.viii

Reducing reluctance among patients and clinicians to engage with new technologies

Providing patients and clinicians with information on the growing evidence of the efficiency and effectiveness of digital technology and improving their education on its use, is a crucial first step to gaining trust and confidence. On-line learning, for example, can increase knowledge of treatment options and improve clinical and psychosocial outcomes.ix Evidence from the X-PERT Diabetes programme has demonstrated savings to the NHS, of some £367 million per year.x

Tackling accessibility and equality of access within the UK

To harness the full potential of technology, financial and regulatory barriers need to be addressed. Currently not all patients with type 1 diabetes are offered insulin pump therapy and fewer still are able to obtain continuous glucose monitoring, and then only after individual funding requests. NICE guidance in February 2016 concluded that routine adoption is not yet supported by sufficient evidence.xi

Diabetes is currently a chronic condition and there is as yet no cure. However, equitable access to technology is an important enabler for improving the monitoring and compliance of treatment while reducing healthcare costs and improving the quality of life for millions of people.

For my friend, it certainly makes all the difference. She did find a beautiful wedding dress. It was a marvellous day and the stains on the dress, were not the result of having to prick her finger repeatedly throughout the day, but rather told the story of a fabulous party.

Footnotes

https://www.diabetes.org.uk/Get_involved/World-Diabetes-Day/

ii   https://www.diabetes.org.uk/Documents/Position%20statements/Diabetes%20UK%20Facts%20and%20Stats_Dec%202015.pdf

iii  https://www.diabetes.org.uk/Guide-to-diabetes/What-is-diabetes/

iv  https://www.diabetes.org.uk/Research/Research-round-up/First-artificial-pancreas-approved-for-use-in-the-United-States/

http://riskscore.diabetes.org.uk/start

vi   https://www2.deloitte.com/uk/en/pages/life-sciences-and-healthcare/articles/primary-care-today-and-tomorrow.html

vii  http://www.forbes.com/sites/reenitadas/2016/11/14/how-technology-will-change-diabetes-management/#4795ffb62eeb

viii  https://www.engineeringforchange.org/eight-tools-and-one-idea-for-ultra-low-cost-diabetes-screening/

ix  https://www2.deloitte.com/uk/en/pages/life-sciences-and-healthcare/articles/connected-health.html

http://selfmanagementuk.org/programmes

xi https://www.nice.org.uk/guidance/DG21/chapter/1-Recommendations 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions